Blue Owl Capital
OWL NYSE Asset Management & Custody Banks Financials FY2019βFY2025
Blue Owl Capital's revenue rose 25.0% to $2.9 billion in fiscal 2025. Its net margin was 2.8%, down from 4.8% a year earlier. Free cash flow was $1.2 billion, up 28.1%. It paid out $600 million in dividends and buybacks, 50% of free cash flow. The diluted share count rose 18.5%.
About these figures. Revenue is Blue Owl's total revenues; another figure in its filings is one part of them (2025: US$568 million of US$2,870 million).
What Blue Owl Capital does
No business description yet.
- Legal name
- BLUE OWL CAPITAL INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001823945-26-000009
0001823945
Revenue and margins
Blue Owl Capital had $2.9B of revenue in fiscal 2025, up 25.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.2B in fiscal 2025, 41.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Blue Owl Capital returned $600M to shareholders in fiscal 2025, 50% of free cash flow. The diluted share count rose 18.5%.
Value Blue Owl Capital yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$3.1B and divides by 661.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 78.0x Β· peers 15.7x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Blue Owl Capital can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $42.6M | $68.1M | $104M | $152M | $195M |
| Debt incl. finance leases | $1.2B | $1.6B | $1.7B | $2.6B | $3.3B |
| Net debt / EBITDA | β | 5.8x | 2.5x | 2.8x | 3.5x |
| Debt / equity | 0.7x | 1.0x | 1.1x | 1.2x | 1.5x |
| Interest coverage | β66.5x | 0.2x | 4.3x | 4.9x | 3.1x |
| Total assets | $8.3B | $8.9B | $8.8B | $11.0B | $12.5B |
| Total liabilities | $2.4B | $3.3B | $3.5B | $5.2B | $6.4B |
| Shareholders' equity | $1.7B | $1.6B | $1.5B | $2.1B | $2.2B |
| Net debt (β = net cash) | $1.1B | $1.6B | $1.6B | $2.4B | $3.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$7.1M
4 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 2, 2025 | Craig PackerCo-President, Director | Bought | 110,227 | $15.06 | $1.7M | Form 4 |
| Dec 2, 2025 | Douglas I OstroverCo-Chief Executive Officer, Director | Bought | 139,327 | $15.06 | $2.1M | Form 4 |
| Dec 2, 2025 | Marc S LipschultzCo-Chief Executive Officer, Director | Bought | 139,326 | $15.06 | $2.1M | Form 4 |
| Dec 1, 2025 | Alan KirshenbaumChief Financial Officer | Bought | 33,670 | $14.87 | $0.5M | Form 4 |
| Dec 1, 2025 | Craig PackerCo-President, Director | Bought | 14,773 | $15.06 | $0.2M | Form 4 |
| Dec 1, 2025 | Douglas I OstroverCo-Chief Executive Officer, Director | Bought | 18,673 | $15.06 | $0.3M | Form 4 |
| Dec 1, 2025 | Marc S LipschultzCo-Chief Executive Officer, Director | Bought | 18,674 | $15.06 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β10.1% | β9.0% | β10.0% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Blue Owl Capital OWL | $6.4B | 25.0% | β | 41.8% | 5.2% | 78.0x | β | |
| SEI Investments SEIC | $12.6B | 8.1% | 27.3% | 25.5% | β | 18.0x | β | Compare β |
| Affiliated Managers Group AMG | $10.3B | 1.6% | β | 46.6% | 16.5% | 13.4x | β | Compare β |
| Federated Hermes FHI | $4.1B | 10.3% | 28.5% | 16.4% | 40.9% | 10.6x | 7 | Compare β |
| TPG TPG | $17.2B | 33.4% | β | β | 15.2% | 66.6x | β | Compare β |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $191M | $250M | $824M | $1.4B | $1.7B | $2.3B | $2.9B |
| Interest expense | $6.7M | $23.8M | $27.7M | $60.1M | $75.7M | $122M | $164M |
| Pretax income | $20.7M | β$82.5M | β$1.9B | β$49.6M | $246M | $469M | $348M |
| Income tax | $0.2M | β$0.1M | β$65.2M | β$9.4M | $25.6M | $48.8M | $42.4M |
| Net income | $23.0M | β$77.8M | β$376M | β$9.3M | $54.3M | $110M | $78.8M |
| Diluted EPS | β | β | β | β$0.02 | $0.10 | $0.20 | $0.10 |
| Diluted shares | β | β | β | 0.43B | 0.48B | 0.56B | 0.66B |
| Cash flow | |||||||
| Cash from operations | $44.1M | $5.2M | $282M | $728M | $949M | $1,000M | $1.3B |
| Capital expenditure | $1.2M | $0.7M | $5.3M | $65.5M | $67.9M | $64.2M | $57.7M |
| Free cash flow | $42.9M | $4.6M | $276M | $663M | $881M | $935M | $1.2B |
| Depreciation and amortization | $0.8M | $0.7M | $115M | $259M | $311M | $275M | $382M |
| Stock-based compensation | $0.0M | $0.0M | $1.2B | $421M | $313M | $313M | $674M |
| Acquisitions | $0.0M | $0.0M | $1.6B | $115M | $26.3M | $445M | $245M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $78.8M | $0.0M | $0.0M | $53.7M |
| Dividends paid | $0.0M | $0.0M | $47.1M | $183M | $248M | $368M | $547M |
| Dividends and buybacks | $0.0M | $0.0M | $47.1M | $261M | $248M | $368M | $600M |
| Balance sheet | |||||||
| Cash and short-term investments | $7.3M | $11.6M | $42.6M | $68.1M | $104M | $152M | $195M |
| Total debt | β | $356M | $1.2B | $1.6B | $1.7B | $2.6B | $3.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | β | $1.3M | β | β | β | β | β |
| Current liabilities | β | $0.1M | β | β | β | β | β |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | β | $3.4M | $8.0M | $71.2M | $135M | $188M | $219M |
| Total assets | β | $122M | $8.3B | $8.9B | $8.8B | $11.0B | $12.5B |
| Total liabilities | β | $623M | $2.4B | $3.3B | $3.5B | $5.2B | $6.4B |
| Shareholders' equity | β$351M | $5.0M | $1.7B | $1.6B | $1.5B | $2.1B | $2.2B |
| Margins | |||||||
| EBITDA margin | 14.8% | β23.2% | β209.4% | 19.7% | 36.5% | 37.7% | 31.2% |
| Net margin | 12.0% | β31.2% | β45.7% | β0.7% | 3.1% | 4.8% | 2.8% |
| FCF margin | 22.5% | 1.8% | 33.6% | 48.4% | 50.9% | 40.8% | 41.8% |
| Returns | |||||||
| Return on capital | β | β | β42.6% | 0.1% | 4.1% | 7.0% | 5.2% |
| Return on equity | β | β | β45.1% | β0.6% | 3.5% | 6.0% | 3.6% |
| Return on assets | β | β | β9.0% | β0.1% | 0.6% | 1.1% | 0.7% |
| Growth | |||||||
| Revenue growth | β | 30.9% | 229.8% | 66.3% | 26.4% | 32.6% | 25.0% |
| Net income growth | β | β439.0% | β | β | β | 101.7% | β28.1% |
| EPS growth | β | β | β | β | β | 100.0% | β50.0% |
| FCF growth | β | β89.3% | 5,932.2% | 139.8% | 32.9% | 6.1% | 28.1% |
| Share count change | β | β | β | β | 10.3% | 16.8% | 18.5% |
| Financial health | |||||||
| Net debt / EBITDA | β | β | β | 5.8x | 2.5x | 2.8x | 3.5x |
| Debt / equity | β | β | 0.7x | 1.0x | 1.1x | 1.2x | 1.5x |
| Interest coverage | 4.1x | β2.5x | β66.5x | 0.2x | 4.3x | 4.9x | 3.1x |
| Current ratio | β | 9.0x | β | β | β | β | β |
| Quick ratio | β | 9.0x | β | β | β | β | β |
| Capital allocation | |||||||
| Capex / revenue | 0.6% | 0.3% | 0.6% | 4.8% | 3.9% | 2.8% | 2.0% |
| Stock comp / revenue | 0.0% | 0.0% | 146.3% | 30.7% | 18.1% | 13.6% | 23.5% |
| Payouts / FCF | 0.0% | 0.0% | 17.0% | 39.4% | 28.1% | 39.4% | 50.1% |
| Quality scores | |||||||
| Altman Z'' | β | β4.2 | β | β | β | β | β |
| Accruals ratio | β | β | β15.7% | β8.6% | β10.1% | β9.0% | β10.0% |
Source: SEC EDGAR XBRL filings (CIK 0001823945). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.